Latest News

Anyone interested in GigaCloud Technology Inc. ( NASDAQ:GCT ) should probably be aware that the President, Iman...

Potential Embecta Corp. ( NASDAQ:EMBC ) shareholders may wish to note that the President, Devdatt Kurdikar, recently...

Global bond markets are being shaken by rising Japanese and U.S. yields, and capital is moving in ways that can reward some Canadian stocks while leaving others exposed. Investors who ignore this cross border rate reset risk missing where money may quietly be rotating next. This article breaks down how the story ties back to Canadian markets and reveals 3 stocks directly exposed to these shifts. The stocks covered below are only a starting sample, and the full screen surfaced 37 more Canadian...

Baker Hughes recently secured multi-year contracts with Kuwait Oil Company for upstream technology innovation and with QatarEnergy to supply equipment for two LNG mega trains at the North Field West Project, alongside new subsea and hydrogen-infrastructure collaborations in Indonesia and Europe. Together, these deals deepen Baker Hughes’ role in digital, AI-driven oil and gas optimization and hydrogen infrastructure, while embedding research and manufacturing footprints closer to key...

International Business Machines has delivered a 117.8% total return over the past five years, yet current valuation checks send a mixed message as the stock screens as undervalued on both intrinsic value estimates and market multiples while only scoring 2 out of 6 on broader tests. A 117.8% gain over five years suggests IBM has already rewarded patient shareholders, so any further upside case rests on how much earnings and cash flow can grow from here. Recent partnerships in artificial...

Yanlord Land Group stock has been drifting lower, with the share price down roughly 9% over the past week as investors digest another loss making half year. The headline from this earnings print is simple: the property developer is still in the red, with H1 2026 net income excluding extra items showing a loss of C¥150.6m and basic earnings per share also in loss making territory. The near term numbers will worry traders focused on momentum. Longer term investors will care more about whether...

Suncorp Group (ASX:SUN) has put fresh capital management plans on the table, pairing a fully franked special dividend with approval for an on market buyback of up to A$250 million in shares. See our latest analysis for Suncorp Group. The capital return announcements come after a solid run for Suncorp Group’s stock, with a 90 day share price return of 12.64% and year to date share price return of 10.67%. The 5 year total shareholder return of 95.91% contrasts with a 1 year total shareholder...

Algonquin Power & Utilities Corp. recently reported past second-quarter 2026 results, showing revenue rising to US$543.9 million while net income fell to US$3.6 million, and concurrently declared common and preferred share dividends in both US$ and C$. The combination of higher revenue but lower earnings, alongside the board’s decision to continue paying dividends, offers a clear view into how Algonquin is balancing operational pressures with shareholder returns. With revenue up but earnings...

Resorttrust stock came into this earnings print with a solid short term run, up about 6% over the past month, and a market label as a quality hospitality and membership club operator on a modest P/E. The headline today is earnings power. Quarterly basic earnings per share landed at about ¥25.7 and net income reached roughly ¥5.5b, feeding into trailing twelve month earnings that keep the valuation looking restrained versus peers. The price reaction now turns on how much weight investors put...

Power Integrations (POWI) has drawn fresh attention after reporting second quarter 2026 results, alongside a new PowiGaN gallium nitride platform rated at 2,200 V, aimed at high-voltage data centers, EVs and renewable-energy applications. See our latest analysis for Power Integrations. The recent product and earnings announcements have come after a sharp pullback in Power Integrations, with the share price down 12.26% over 30 days and 14.92% over 90 days, yet still showing a 67.05% year to...

Hikari Tsushin stock entered this earnings report with a solid 90-day gain and a modest pullback over the past week, which suggested expectations were high but not euphoric. The headline this quarter is margin power. Net profit margin over the last year was 21% compared with 14.1% a year earlier, and trailing earnings growth of about 59.8% exceeded the company’s own five-year average. At a P/E of 10.6x, the market reaction now has to weigh that earnings strength against concerns around cash...

Olam Group shares closed at S$1.20 on Friday after a choppy few weeks, with the stock down almost 10% over seven days. Yet the headline from this half year is not the share price; it is how thin the business now runs. Trailing net profit margin sits at 0.1% and interest costs have not been well covered by recent earnings. For anyone thinking beyond today’s tick-by-tick moves, this earnings release is really a story about balance sheet strain versus growth hopes. Forecasts in the release point...

Voyager Technologies, Inc. ( NYSE:VOYG ) shareholders will have a reason to smile today, with the analysts making...

In the recent past, Greenbrier Companies reported quarterly results showing a 31.6% year-on-year revenue decline that missed analysts’ expectations, and it reduced its full-year guidance, highlighting ongoing operational and demand pressures in its heavy transportation equipment business. This weaker quarter left Greenbrier lagging peers in the sector, sharpening investor focus on whether its cost-efficiency efforts and railcar backlog can offset softer demand. We’ll now examine how...

Thakral’s stock closed at SGD1.74 on Friday after a choppy few months, with the price drifting lower even before investors saw the latest numbers. The earnings headline is blunt. Management moved from strong profitability to a net loss of SGD6.423 million for the first half of 2026, despite reporting revenue of SGD189.374 million. The trailing P/E multiple now sits at 4.8x compared with much higher industry peers, which leaves the market trying to decide whether this sell off reflects a fair...

Nanofilm Technologies International heads into the weekend at SGD1.05, with the stock down over the past week, month and quarter. The market is clearly cautious in the short term. The headline from H1 2026 is quieter but more important. Revenue stands at SGD113.7m and net income is SGD4.3m, which keeps the trailing net margin broadly steady at about 5.8%. For a precision coatings and materials specialist that is capital intensive, the real story now sits in how that slim profitability profile...

Natera stock has delivered a very large return over the past three years, yet the valuation checks send a mixed signal, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to a sizeable discount while market based multiples lean expensive. Natera has returned very close to 5x over the past three years, which puts recent gains front and center in any valuation discussion. Recent revenue momentum and expanding test adoption can support optimism around long term cash...

Eli Lilly (NYSE: LLY) has launched a legal crackdown on illicit U.S. sales of its experimental obesity drug retatrutide, which is not approved for any use. The company has filed six lawsuits against U.S.-based entities that it says are selling or promoting retatrutide outside authorised clinical channels. Lilly is also urging broader industry and regulatory action, highlighting patient safety concerns and risks to its obesity drug franchise. This kind of legal push around obesity treatments...

Anyone interested in Cerence Inc. ( NASDAQ:CRNC ) should probably be aware that the Executive VP, Jennifer Salinas...

JINGDONG Industrials stock closed at HK$13.49 on Friday, almost flat over the past month and modestly weaker over three months. The market looks undecided. The earnings headline is clearer. H1 2026 revenue came in at C¥13,062.8m with basic earnings per share of C¥0.23. Those figures sit inside a trailing twelve month picture that still carries a heavy C¥1.4b one off gain, which leaves many investors asking how much of the apparent profitability is repeatable. Is JINGDONG Industrials trading...

Pan-United stock held flat over the past week and came into today with only a small gain over the past month, even as the company reported another set of firm earnings. The market has not chased the story, yet the latest half-year numbers show earnings per share at SGD0.0438 and net income of SGD30.62 million on revenue of SGD552.15 million. The real tension for investors sits in the sentiment gap. Profit growth and slightly better margins are on the table, while a richer P/E and questions...

Frencken Group stock came into these H1 2026 results on a weak three month run, down about 17% over 90 days, even as the latest close sat at SGD2.63. The headline from the numbers is not revenue, which held around SGD400 million, but profitability. Net profit margin sits near 4.5% and the trailing P/E is about 29x, above the Asian machinery average and with the share price already well above a discounted cash flow estimate. For short term traders that mix may feel tight. For longer term...

RHÖN-KLINIKUM (XTRA:RHK) stock action is drawing attention after the company issued 2026 revenue guidance of about €1.7b, plus or minus 5%, alongside its latest quarterly and half year earnings report. See our latest analysis for RHÖN-KLINIKUM. That guidance and the stronger second quarter and half year earnings land against a share price that has risen 17.2% over the past week and 19.1% over the past 90 days, while RHÖN-KLINIKUM’s 1 year total shareholder return of 33.7% contrasts with a...

Sumitomo Pharma Co., Ltd. reported first-quarter 2026 results with sales of ¥129,495 million and net income of ¥16,997 million, both higher than a year earlier, alongside basic earnings per share from continuing operations of ¥39.02. Separately, Sumitomo Pharma America, Inc. advanced its regenerative medicine efforts as the first patient received DSP-3077 iPS cell-derived retinal sheet implantation in an early-stage trial for non-syndromic retinitis pigmentosa, underlining the group’s push...